Browsing Tag
Róbert Wessman
1 post
Alvotech (NASDAQ: ALVO) reshuffles leadership as Anil Okay takes over Adalvo — is this a turning point for biosimilars?
Discover how Alvotech’s CCO Anil Okay’s move to Adalvo’s CEO seat could reshape commercial leadership, investor sentiment, and the global biosimilar race.